Medications

Terlipressin bests placebo in type 1 hepatorenal syndrome

(HealthDay)—For patients with type 1 hepatorenal syndrome (HRS-1), terlipressin is more effective than placebo for reversal of HRS, according to a study published in the March 4 issue of the New England Journal of Medicine.

Surgery

Tailored education system to benefit kidney transplant patients

Patients with chronic kidney disease and end-stage renal disease have to go to a dialysis center for hours at a time, several times a week for the rest of their lives. Patients on dialysis have strict dietary restrictions, ...

page 5 from 20